Septicemia and bloodstream infections (BSIs) are major causes of neonatal morbidity and mortality in developing countries. We prospectively recorded all positive blood cultures (BSI) among neonates admitted consecutively to a tertiary pediatric hospital in Vietnam during a 12-month period. Among 5763 neonates, 2202 blood cultures were performed, of which 399 were positive in 385 neonates. Among these, 64 died, 62 in relation to septicemia. Of the BSI isolates, 56% was known pathogenic and 48% was gram-negative bacteria, most frequently Klebsiella spp. (n ¼ 78), Acinetobacter spp. (n ¼ 58) and Escherichia coli (n ¼ 21). Only three Streptococcus spp. were identified, none group B. Resistance against antibiotics applied was common. The mortality was highest in neonates with gram-negative BSI compared with no confirmed BSI and gram-positive BSI (P < 0.01). In this setting, the majority of BSI were likely to have been transmitted from the environment. Improvement of hygienic precautions and systematic BSI surveillance are recommended.
Introduction
Globally, infections cause more than a third of the deaths among neonates (28 days of age), the vast majority in the developing countries [1] [2] [3] [4] .
Septicemia is among the most severe infections usually defined by a positive blood culture (bloodstream infections, BSI) and systemic clinical signs. In the absence of consensus of specified diagnostic criteria, blood culture is considered the gold standard to establish the diagnosis [5] [6] [7] . As septicemia is difficult to diagnose on presentation and may develop rapidly, prompt empirical treatment is prescribed and later adjusted according to blood culture result and clinical response.
The etiologies of BSI vary in time and place. Compared with high-income countries, neonatal septicemia in lower-income countries is more frequent, more commonly caused by gram-negative bacteria, and mortality higher. Furthermore, antibiotic resistance is an increasing problem [8] [9] [10] [11] [12] . Vietnam has risen from one of the poorest countries in the world to a lower middle-income country, with almost 90% of women delivering in health-care facilities [13] . To our knowledge, no peer-reviewed study is available on neonatal septicemia or BSI in Vietnam, and few are published from the region [12, 14, 15] .
Our aim was to characterize the pattern of neonatal BSI in a tertiary hospital in Vietnam. We investigated the incidence, distribution and antibiotic susceptibility of microbial species. Furthermore, we examined the septicaemia-related mortality among neonates with BSI and the association to group of species.
Patients and Methods

Setting
The study was conducted at The Pediatric Hospital Number 1 in Ho Chi Minh City (PH1). It provides pediatric care only and is a tertiary referral hospital for South Vietnam, in 2009 comprising 726 578 live births corresponding to half of the deliveries in the country [16] . In PH1, approximately 95% of the 86 000 patients admitted annually are referred from other health-care facilities, 2/3 from the provinces and 1/3 from the city. The 150-bed neonatal department offered the most specialized care in the country.
Participants and data collection
During the 12-month study period from February 2009 to February 2010, a prospective cohort was established of all neonates (28 days of age) admitted to PH1. Basic demographic and clinical data were obtained from the central hospital registry, including data on gender, birth date, admission period, discharge diagnoses using the International Classification of Diseases version 10 (ICD 10) [17] and discharge outcome. To ensure correct registration of neonatal deaths, dead cases were also listed separately by the project group throughout the study period according to clinical staff, ward books, ward meetings and daily hospital conferences.
The indication for blood culture was severe clinical signs of septicemia, often supported by other paraclinical results. Culture was performed prophylactic only in the few cases of exchange transfusion.
Results of blood cultures were collected from the registration book and electronic database in the Department of Microbiology. When a culture was positive, sampling date, isolate and antibiotic susceptibility pattern were registered.
Laboratory methods
A peripheral blood sample of 1-2 ml was drawn into a pediatric blood culture bottle (BACTEC, Becton Dickinson, NJ) after skin disinfection with povidone-iodine and alcohol. Bacterial growth was detected automatically (BACTEC 9240/9050 reader). Blood culture bottles were incubated for 6 days. If negative, a 1-day subculture confirmation was carried out. If positive, cultures were examined by microscopy of gram-stained smears and cultured on 5% sheep blood agar and MacConkey agar at 35 C moist air. If fungal infection was suspected, Sabouraud agar was included. The agar plates were manufactured at the laboratory of PH1 from purchased ingredients (Becton Dickinson). Bacterial isolates were identified by conventional methods [18] using commercially available media (Bio-Rad, Philadelphia, PA). Based on gram stain, antibiotic susceptibility of pathogens was tested on Mueller Hinton agar (Becton Dickson) using disc diffusion (Oxoid, Hampshire, UK) for relevant antibiotics [19] .
Data analysis
Data were analyzed in STATA IC 11 (StataCorp, College Station, TX). Each death among neonates with BSI was audited to determine whether it was a septicemia-related neonatal death, defined as septicemia assigned as either direct or underlying death cause according to ICD 10. The audit group included experienced neonatologists and pediatricians from PH1 and Rigshospitalet (Denmark). To test the association between grouped isolates and septicemia-related neonatal death, chi-squared test was performed (2-sided P-value set to 5%).
Ethical approval
The study was approved by The Scientific Review Board and Ethical Committee of the study hospital and The Danish Data Protection Agency. The study is not within the jurisdiction of The Danish National Committee on Health Research Ethics, Subcommittee on Developing Countries.
Results
Patients
In the study period, 5802 neonates were admitted to the hospital. Thirty-nine neonates, none with BSI, were excluded due to lack of basic data (<1%). The remaining 5763 neonates constituted the cohort previously described [20] , of which 34% were admitted at age 0-3 days and 62% were diagnosed with infection. Overall neonatal case fatality rate was 4%.
Bloodstream Infections
In the cohort, 2202 neonates had blood cultures performed, of which 399 samples in 385 neonates were positive. Fourteen neonates had two positive cultures performed with different isolates at different times (>3 days apart). BSI was verified in 1.3/1000 admission days.
Characteristically, the majority of neonates with BSI had late-onset BSI (>3 days of age) (84%) and infection as discharge diagnosis (64%). Sixty-four died (17%) ( Table 1) .
Isolates
Of the BSIs, 56% were caused by isolates considered known pathogenic ( Table 2) . The remaining isolates, all coagulase-negative Staphylococcus (CoNS), were considered potentially pathogenic. Among the pathogenic isolates, 86% were gram-negative bacteria, with Klebsiella spp., Acinetobacter spp., Escherichia coli and Enterobacter spp. being the most frequent isolates recovered. Streptococci were isolated in only three neonates and were alpha-hemolytic. Several of the species were not specified.
Mortality
Sixty-four deaths occurred among the neonates with BSI, 62 (97%) were classified as septicemia-related neonatal deaths corresponding to a case fatality rate of 16% (62/385). The mortality was significantly higher among neonates with confirmed BSI, and the risk varied by group of isolates (P < 0.01, Table 3 ). CoNS seemed of clinical interest compared with those without confirmed BSI. As expected, the mortality risk was significantly higher among neonates with gram-negative BSI.
Susceptibility to antibiotics
Decreased antibiotic susceptibility was common among the isolate groups, including resistance toward antibiotics used empirically in the hospital (Table 4) . Hence, resistance toward both first-line (ampicillin, gentamicin and cefotaxime) and second-line (other cephalosporins and quinolones) treatments was substantial among the gram-negative bacteria. Susceptibility was retained for the broad-spectrum carbapenems used as third-line therapy, although Acinetobacter spp. showed emerging resistance (43%). Among Staphylococcus aureus, methicillin (oxacillin) resistant accounted for 45%. No vancomycin resistance was found among the gram-positive bacteria.
Discussion BSI was diagnosed in almost one-fifth of blood cultures performed in this neonatal hospital cohort. In contrast to the high proportion of gram-negative isolates, Streptococci spp. isolates were rare, resembling the pattern reported in other resource-limited settings (8) (9) (10) (11) (12) 14) .
The study population was selected and not likely to be representative of the huge catchment population of live births delivered outside the hospital [20] . The vast majority was referred to this tertiary hospital from other health-care facilities. Early-onset BSI were underrepresented, as the majority of neonates were >3 days old at admission. Some neonates are likely to have died before or been evaluated too severely ill for referral, because transport is often long and only basically equipped. Furthermore, the staff or family may have regarded the prognosis too poor to justify the direct and indirect expenses involved in referral to higher level of care.
We studied BSI as a surrogate for septicemia, as only limited clinical and paraclinical data were accessible. We assumed neonates with BSI to have signs of septicemia, as it was the main indication for blood culture. We also expected infection diagnosis to be a rough indicator of clinically relevant infections. However, the relation between BSI and infection discharge diagnosis was poor. Several explanations for this are possible. Infection diagnosis might not have been assigned when other diagnoses were relevant. Infection diagnoses also included localized infections and other invasive infections. Further, the validity of discharge diagnoses and ICD may be disputed [21, 22] . The predominance of Klebsiella spp., Acinetobacter spp. and E. coli is in accordance with other hospital studies in developing countries [8] [9] [10] [11] [12] 14] . Acinetobacter spp. was less pathogenic than the other gram-negative bacteria identified in the study, but still a significant cause of death. Due to emergence of multiresistance, this species may play an increasing role in septicemia-related mortality [23] [24] [25] . The majority of BSIs were late-onset and likely to have been transmitted from the environment via care providers, including nosocomial infections acquired at PH1 or the previous health-care facility. However, misclassification of onset is possible, as BSIs might have been present earlier than diagnosed. Standard blood culture at admission during a surveillance period could help to locate the source. Nosocomial transmission is well-known for the majority of the isolates identified [10] [11] [12] , and hygienic precautions are of major importance to prevent BSI.
The importance of CoNS in neonatal septicemia has been disputed. Our findings suggest they may be of clinical relevance, although few neonates had central vascular catheters, which are associated with CoNS colonization of pathogenic importance [7, 8, 11, 26] . Only three streptococci were recovered, non--beta-hemolytic. Streptococcus group B is a leading cause of neonatal septicemia in high-income countries, but less frequently reported in lower-income countries, and especially in Southeast Asia. However, the burden in developing countries is unclear [8, 12, [27] [28] [29] [30] [31] [32] .
The overall mortality was significantly higher among neonates with BSI, as expected, and within the range shown by others in resource-scarce settings [8, 14, 33] . We classified 97% of deaths among neonates with BSI as septicemia-related neonatal deaths, according to audit ICD10 classification. However, in most deaths, more causes were present. Congenital malformation, prematurity (gestational age <33/low birth weight <1800 g) and asphyxia are other major causes of neonatal mortality globally [2, 34] . These conditions were present in 40-60% of septicemia-related neonatal deaths in the isolate groups compared. It should also be kept in mind that severely ill neonates are at high risk of infection and prone to have blood culture performed, hence it is difficult to determine whether BSI was the cause or the consequence of severe illness.
Antibiotic treatment at the time of sampling was not reported. Resistance against the first lines of antibiotics applied in the hospital was a common problem. Increasing antibiotic resistance, especially among gram-negative bacteria, is a major concern in developing countries [8] [9] [10] [11] [12] [32] [33] [34] [35] [36] [37] [38] . The use of antibiotics in and outside health-care facilities and in farming is a likely cause [36, 37, 39] . Carbapenems could be considered as the first choice for gram-negative BSIs with severe clinical signs of septicemia in this setting, but meropenem-resistant Acinetobacter spp. should be monitored carefully [40] .
Among gram-positive bacteria, vancomycin susceptibility was preserved. Almost half of Staphylococcus aureus isolates were methicillin-resistant, but numbers were too small to allow any firm conclusions.
Future alternatives to initiate effective antibiotics in emerging economy countries like Vietnam could be targeting antibiotics fast by identification of isolates using matrix-assisted laser desorption ionization-time of flight [41, 42] or hybridization techniques [6, 43] .
Conclusion Among all 2202 blood cultures, 399 BSI were verified among 385 neonates. The majority was late-onset and caused by known pathogenic species. Gramnegative bacteria comprised the vast majority, of which Klebsiella spp., Acinetobacter spp. and E. coli were the most frequent. No Streptococcus group B isolates was identified. The septicemia-related mortality was highest among neonates with gram-negative BSI. Resistance towards antibiotics applied in the hospital was common, and carbapenems could be considered first choice for gram-negative BSI with severe clinical signs. Improvement of hygienic precautions and implementation of BSI surveillance are recommended to decrease septicemia morbidity and mortality among hospitalized neonates in Vietnam. 
